Evidence map›Paper›PMID 29655379›Full record

ArticleEpidemiology and infection2018

Shigella infection in children under 5 years old in western French Guiana.

M Parisot, N Parez, R Boukhari, S Breurec, A Jolivet

Open access · bronzeAbstract read
In one paragraph

Article in Epidemiology and infection, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Shigella in Africa: New Insights From the Vaccine Impact on Diarrhea in Africa (VIDA) Study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Article
  3. Review
  4. Article
  5. Toxins · 2021
    Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

M ParisotDepartment of Paediatric,Franck Joly Hospital,St-Laurent du Maroni,French Guiana,France.
N ParezDepartment of Paediatric,Franck Joly Hospital,St-Laurent du Maroni,French Guiana,France.
R BoukhariDepartment of Clinical Biology,Franck Joly Hospital,St-Laurent du Maroni,French Guiana,France.
S BreurecDepartment of Bacteriology,University Health Centre,Pointe-à-Pitre Abymes,Guadeloupe,France.
A JolivetDepartment of Public Health,Franck Joly Hospital,St-Laurent du Maroni,French Guiana,France.
University of French Guiana · GFCentre Hospitalier Universitaire Pointe-à-Pitre · GPInstitut Pierre Louis d‘Épidémiologie et de Santé Publique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

French Guiana, a tropical country, is characterised by a young and multi-ethnic population. Difficulties in accessing safe water sources lead to outbreaks of gastroenteritis. The objectives of this study were (1) to describe the microbiological profile of shigella strains isolated in western French Guiana, including antimicrobial susceptibility and the distribution of strains in terms of species and serotypes and (2) to estimate the incidence of shigellosis in children under 5 years old. A retrospective observational study was conducted of 213 cases of shigellosis diagnosed in the biology department of the hospital centre for western French Guiana between 2000 and 2012 in children under 5 years old. The serogroups (formerly known as species) that predominates in French Guiana was Shigella flexneri. No resistance was observed to fluoroquinolones or to third-generation cephalosporins. The average incidence of shigellosis in children under 5 years old in western French Guiana was estimated at 189.6 cases per 100 000 inhabitants per year. Shigellosis is a public health problem in western French Guiana. These infections suggest the difficulties in accessing safe water sources and the lack of public sanitation. A quadrivalent vaccine containing Shigella sonnei and three serotypes of S. flexneri (S. flexneri 2a, 3a and 6) could provide broad coverage against shigella infections.

Indexed as

Drug Resistance, BacterialAnti-Bacterial AgentsChild, PreschoolDysentery, BacillaryFemaleFrench GuianaHumansIncidenceInfantInfant, NewbornMalePrevalenceRetrospective StudiesSeasonsSerogroupShigellaAnti-Bacterial AgentsAntibiotic resistancediarrhoeadysentery (bacillary)epidemiologyshigella

Identifiers

PMID29655379
PMCPMC9184929
OpenAlexW2800963163

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.